Hikma Pharmaceuticals (GB:HIK) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hikma Pharmaceuticals PLC has disclosed transactions by a key managerial figure, Bassam Kanaan, involving the sale of company shares. Kanaan sold 35,000 shares at £19.60 each and another 10,000 shares at £20.25 each on the London Stock Exchange. The transactions, initially notified and totaling nearly £888,500, were executed on the 8th and 9th of August 2024.
For further insights into GB:HIK stock, check out TipRanks’ Stock Analysis page.